Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01867099 · ClinicalTrials.gov registry record
Ten-year Outcomes After AF Ablation
A clinical trial, sponsored by Valley Health System.
- Completed
- Registry status
- 445
- Enrollment target
NCT01867099: Completed study, sponsored by Valley Health System.
NCT01867099 is a clinical trial that has completed, run by Valley Health System. The registered enrollment target is 445 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01867099 has completed, sponsored by Valley Health System.
- COMPLETED
- Registry status
- 445 participants
- Enrollment target
Study Summary
Ablation of atrial fibrillation (AF) using pulmonary vein isolation is employed when patients do not respond favorably to medical therapy. Successful procedures are accomplished in the majority of patients, but the outcome after many years of follow-up after ablation is unknown.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 445 participants |
| Start Date | 2002-12 |
| Est. Completion | 2012-12 |
What the finished NCT01867099 record still lists
NCT01867099 is an observational study that tracks outcomes without assigning an intervention. The registered 445 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01867099 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01867099 about?
NCT01867099 is a clinical study titled "Ten-year Outcomes After AF Ablation". Ablation of atrial fibrillation (AF) using pulmonary vein isolation is employed when patients do not respond favorably to medical therapy. Successful procedures are accomplished in the majority of patients, but the outcome after many years of follow-up after ablation is unknown.
What is the current status of trial NCT01867099?
This trial is currently completed. The enrollment target is 445 participants. The study started on 2002-12. Estimated completion is 2012-12.
Who is sponsoring clinical trial NCT01867099?
This trial is sponsored by Valley Health System, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01280994 · 445 participants · Phase 2
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
- NCT03504800 · 445 participants
OCT in Diagnosis of Irregular Corneas
- NCT04751435 · 445 participants · NA
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
- NCT06348394 · 444 participants · NA
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia